Nxstage Medical (NXTM) Reports In-Line Q4 EPS; Issues Light FY16 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
NxStage Reports Record Fourth Quarter and Full-Year 2015 Revenue
February 10, 2016 8:04 AM ESTLAWRENCE, Mass., Feb. 10, 2016 /PRNewswire/ -- Â
Highlights:
Full-Year Revenue Increases to $336 million, up 11% from 2014 Full-Year Home Revenue Increases to $183 million, up 16% from 2014 Full-Year Operating Income from Products Business Increases to $9 million Company Highlights Significant Product Introductions for the Next Three Years For Third Consecutive Year, Company Targets 15% Annual Home Revenue GrowthNxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today reported record revenue for the fourth quarter and fiscal year ended... More
